Sign in

HSIC on Nasdaq

Henry Schein

Logo: henryschein.com6

American healthcare company

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.3 Its shares trade on Nasdaq under the symbol HSIC.1 Wikipedia text CC BY-SA 4.0

$84.78 up 0.10 (0.12%)Price as of Oct 21, 2026 at 18:59 UTC

Last updated Oct 21, 2026.

Overview

1932Founded1

Compare with Patterson Companies or Owens & Minor, or pick any stock.

  • TickerHSIC on Nasdaq1
  • IndustryWholesale-Medical, Dental & Hospital Equipment & Supplies1
  • HeadquartersMelville1
  • Founded inQueens1
  • Websitewww.henryschein.com
  • Legal formDelaware corporation, Public limited company (Belgium)1
  • Incorporated inDE7
  • Business address135 Duryea Rd, Melville, Ny 117477
  • Filer categoryLarge accelerated filer7
  • LEIVGO3WGL8H45T73F4RR924
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 23201924

See how the biggest companies compare on our leaderboards

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

31.1%Gross margin10
5.0%Operating margin10
3.0%Net margin10
4.0%Revenue growth, 202510
12.3%Return on equity10

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Global Distribution and Value-Added Services brought in 84% of the revenue Henry Schein broke down this way in fiscal 2025.

  1. Global Distribution and Value-Added Services$11.1B1084%up 4% from 2024
  2. Global Specialty Products$1.4B1011%up 6% from 2024
  3. Global Technology$675.0M105%up 7% from 2024
Business segments by year
Business segments202320242025
Global Distribution and Value-Added Services$10.6B$10.8B$11.1B
Global Specialty Products$1.2B$1.3B$1.4B
Global Technology$602.0M$630.0M$675.0M

Regions

United States brought in 69% of the revenue Henry Schein broke down this way in fiscal 2025.

  1. United States$9.1B1069%up 3% from 2024
  2. Outside the United States$4.1B1031%up 6% from 2024
Regions by year
Regions202320242025
United States$8.7B$8.8B$9.1B
Outside the United States$3.7B$3.8B$4.1B

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue69¢$9.1B
  • Selling, general and admin23¢$3.1B
  • Other costs3¢$347.0M
  • Interest1¢$150.0M
  • Income tax1¢$126.0M
  • Profit3¢$398.0M

Out of $13.2B in revenue.10

Where each dollar of operating cash went, fiscal 2025

  • Share buybacks100¢$850.0M

Out of $712.0M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.10

Financial statements

Revenue1112131410$13.2B in 2025+32% since 2019
0$5.0B$10.0B$15.0B2019: $10.0B$10.0B20192020: $10.1B$10.1B2020+1%2021: $12.4B$12.4B2021+23%2022: $12.6B$12.6B2022+2%2023: $12.3B$12.3B2023−2%2024: $12.7B$12.7B2024+3%2025: $13.2B$13.2B2025+4%
Gross profit1112131410$4.1B in 2025+33% since 2019
0$2.0B$4.0B$6.0B2019: $3.1B$3.1B20192020: $2.8B$2.8B2020−9%2021: $3.7B$3.7B2021+30%2022: $3.8B$3.8B2022+4%2023: $3.9B$3.9B2023+1%2024: $4.0B$4.0B2024+4%2025: $4.1B$4.1B2025+2%
Operating income1112131410$653.0M in 2025−9% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $718.3M$718.3M20192020: $535.0M$535.0M2020−26%2021: $852.0M$852.0M2021+59%2022: $747.0M$747.0M2022−12%2023: $615.0M$615.0M2023−18%2024: $621.0M$621.0M2024+1%2025: $653.0M$653.0M2025+5%
Net income1112131410$398.0M in 2025−43% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $694.7M$694.7M20192020: $404.0M$404.0M2020−42%2021: $631.0M$631.0M2021+56%2022: $538.0M$538.0M2022−15%2023: $416.0M$416.0M2023−23%2024: $390.0M$390.0M2024−6%2025: $398.0M$398.0M2025+2%

Every line of the income statement as filed: the last 3 fiscal years, latest first.10

Period ending2025-12-312024-12-312023-12-31
Net sales$13.2B$12.7B$12.3B
Cost of sales$9.1B$8.7B$8.5B
Gross profit$4.1B$4.0B$3.9B
Selling, general and administrative$3.1B$3.0B$3.0B
Depreciation and amortization$263.0M$251.0M$209.0M
Restructuring and related costs$105.0M$110.0M
Operating income$653.0M$621.0M$615.0M
Interest income$33.0M$24.0M$17.0M
Interest expense-$150.0M-$131.0M-$87.0M
Other, net-$3.0M-$1.0M-$3.0M
Income before taxes, equity in earnings of affiliates and noncontrolling interests$533.0M$513.0M$542.0M
Income taxes-$126.0M-$128.0M-$120.0M
Equity in earnings of affiliates, net of tax$12.0M$13.0M$14.0M
Net Income$419.0M$398.0M$436.0M
Less: Net income attributable to noncontrolling interests-$21.0M-$8.0M-$20.0M
Net income attributable to Henry Schein, Inc.$398.0M$390.0M$416.0M
Basic (in dollars per share)$3.29$3.07$3.18
Diluted (in dollars per share)$3.27$3.05$3.16
Basic (in shares)120.8M shares126.8M shares130.6M shares
Diluted (in shares)121.7M shares127.8M shares131.7M shares

Compare Henry Schein with another company

Corporate structure

Henry Schein sits at the top of its group. 66 entities, 14 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Henry Schein

  • Henry Schein Melville, New York, United States
    • ACE Surgical Supply Co., Inc. Subsidiary · Massachusetts, United States
    • ALTATEC GMBH Subsidiary · Wimsheim, Germany
    • ANIMAL HEALTHCARE SERVICES LIMITED Subsidiary · Sheffield, United Kingdom
    • ARSEUS LAB B.V. Subsidiary · Zeist, Netherlands
    • BHCL US Holdings Inc. 1 Subsidiary · Delaware, United States
    • CAMLOG BIOTECHNOLOGIES GMBH Subsidiary · Basel, Switzerland
    • Camlog USA, Inc. 2 Subsidiary · Delaware, United States
    • Cliniclands AB Subsidiary · Göteborg, Sweden
    • COVETRUS IE LIMITED Subsidiary · Annacotty, Ireland
    • DENTAL TREY - SOCIETA' A RESPONSABILITA' LIMITATA Subsidiary · Predappio, Italy
    • Dentalplans.com Subsidiary · United States
    • eAssist, Inc. 3 Subsidiary · Wyoming, United States
    • Exan Enterprises Inc. 4 Subsidiary · Nevada, United States
    • Handpiece Parts & Repairs, Inc. 5 Subsidiary · Delaware, United States
    • Henry Schein (Lancaster, PA) Inc. Subsidiary · Pennsylvania, United States
    • HENRY SCHEIN ANIMAL HEALTH HOLDINGS LIMITED Subsidiary · Gillingham, United Kingdom
    • HENRY SCHEIN DENTAL B.V. Subsidiary · Almere, Netherlands
    • HENRY SCHEIN DENTAL DEUTSCHLAND GMBH Subsidiary · Langen, Germany
    • HENRY SCHEIN ESPAÑA SL. Subsidiary · Madrid, Spain
    • Henry Schein Europe, Inc. 6 Subsidiary · Delaware, United States
    • HENRY SCHEIN EUROPEAN HOLDING B.V. Subsidiary · Almere, Netherlands
    • HENRY SCHEIN EUROPEAN SERVICES B.V. Subsidiary · Almere, Netherlands
    • HENRY SCHEIN FRANCE SCA Subsidiary · Joué-Lès-Tours, France
    • Henry Schein Global Sourcing, Inc. 7 Subsidiary · Delaware, United States
    • HENRY SCHEIN GMBH Subsidiary · Langen, Germany
    • and 39 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Henry Schein reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$1.4B10 Dec 27, 2025$1.2B10 Dec 28, 2024+14.9%
Accumulated depreciation$759.0M10 Dec 27, 2025$670.0M10 Dec 28, 2024+13.3%
Finance-lease assets$7.0M10 Dec 27, 2025$7.0M10 Dec 28, 20240%
Operating-lease assets (leased space)$301.0M10 Dec 27, 2025$293.0M10 Dec 28, 2024+2.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$4.2B10 Dec 27, 2025$3.9B10 Dec 28, 2024+8.4%
Intangible assets, net (excluding goodwill)$1.0B10 Dec 27, 2025$1.0B10 Dec 28, 2024−0.5%
Finite-lived intangibles, gross$1.7B10 Dec 27, 2025$1.6B10 Dec 28, 2024+6.5%
Accumulated amortization$638.0M10 Dec 27, 2025$532.0M10 Dec 28, 2024+19.9%
Finite-lived intangibles, net$1.0B10 Dec 27, 2025$1.0B10 Dec 28, 2024−0.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$2.0B10 Dec 27, 2025$1.8B10 Dec 28, 2024+10.6%
Raw materials$70.0M10 Dec 27, 2025$61.0M10 Dec 28, 2024+14.8%
Work in process$43.0M10 Dec 27, 2025$39.0M10 Dec 28, 2024+10.3%
Finished goods$1.9B10 Dec 27, 2025$1.7B10 Dec 28, 2024+10.5%

The story

In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.

In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.

Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.

In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.

Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.

In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.

In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.

Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.

Read the full text

In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.

In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.

In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.

On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.

In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.

In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.

From Wikipedia’s article on Henry Schein, shared under CC BY-SA 4.0.8

Leadership

Who has led Henry Schein, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Stanley M. Bergman2006–2012
  2. Lonnie Shoff2012–2016
  3. James P. Breslawski2013–2018
  4. Karen Prange2016–2018
  5. Bradford C. Connett2021–2024
  6. David B. Brous Jr.2021–2023
  7. Andrea Albertini2024–2025
  8. Thomas C. Popeck2025–2026
  9. Frederick M. Lowery2026–now

Chair

  1. Stanley M. Bergman2006–now

President

  1. James P. Breslawski2006
  2. Michael Racioppi2006–2008
  3. Michael Zack2006–2013
  4. Robert Minowitz2013–2016
  5. Bridget A. Ross2017

Chief financial officer

  1. Steven Paladino2006–2022
  2. Ronald N. South2022–now

Chief operating officer

  1. James P. Breslawski2006–2013
  2. Michael S. Ettinger2023–now
197019801990200020102020
Board members and other officers (44)

Products and brands

Operations

Dental

In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.

Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.

Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.

In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.

Read the full text

In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.

In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.

In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.

In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.

In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.

In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.

Henry Schein One

In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.

In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.

In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.

In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.

Medical

In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.

In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.

In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.

In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.

In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).

In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).

Former division

Animal health

Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.

From Wikipedia’s article on Henry Schein, shared under CC BY-SA 4.0.8

Subsidiaries and ownership

Subsidiaries

  • Dentalplans.com
  • HENRY SCHEIN

Subsidiaries (Exhibit 21)

  • ACE Surgical Supply Co., Inc. Massachusetts9
  • BHCL US Holdings Inc. 1 Delaware9
  • Camlog USA, Inc. 2 Delaware9
  • Exan Enterprises Inc. 4 Nevada9
  • HS Brand Management, LLC Delaware9
  • HS Financial Holdings, Inc. 11 Delaware9
  • HS TM Holdings, LLC 12 Delaware9
  • HSFR, Inc. Delaware9
  • HSG-S Corp. 13 Delaware9
  • HSI Gloves, Inc. Delaware9
  • HSI RE I, LLC Delaware9
  • Handpiece Parts & Repairs, Inc. 5 Delaware9
  • Henry Schein (Lancaster, PA) Inc. Pennsylvania9
  • Henry Schein Europe, Inc. 6 Delaware9
  • Henry Schein Global Sourcing, Inc. 7 Delaware9
  • Henry Schein Home Health, LLC 8 Delaware9
  • Henry Schein International LLC Delaware9
  • Henry Schein Latin America Pacific Rim, Inc. 9 Delaware9
  • Henry Schein MSO, LLC Delaware9
  • Henry Schein Medical Systems, Inc. Ohio9
  • Henry Schein PPT, Inc. Wisconsin9
  • Henry Schein Practice Solutions Inc. 10 Utah9
  • Henry Schein Puerto Rico, Inc. Puerto Rico9
  • Henry Schein Supply, Inc. New York9
All 35 listed subsidiaries
  • Insource, Inc. Virginia9
  • Modern Laboratory Services, Inc. California9
  • Ortho2, LLC Delaware9
  • Project Helium Holdings, LLC 14 Delaware9
  • Project Spartan Holdings Corp. 15 Delaware9
  • S & S Discount, Inc. 16 Delaware9
  • SAS Holdco, Inc. 17 Delaware9
  • TDSC, Inc. Delaware9
  • Toy Products Corp. 18 Delaware9
  • Trimed, Inc. 19 California9
  • eAssist, Inc. 3 Wyoming9

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • SCHEIN HENRY INCMay 13, 1996 to Jun 19, 20067

Timeline

  1. Oct 8, 20268-K Executive or director change; Regulation FD disclosure74
  2. Sep 22, 20268-K Entered a material agreement; New debt or obligation75
  3. Aug 4, 20268-K Results of operations76
  4. Jul 30, 20268-K Executive or director change; Regulation FD disclosure77
  5. May 22, 20268-K Shareholder vote; Regulation FD disclosure78
  6. May 5, 20268-K Results of operations79
  7. Mar 2, 2026New chief executive Frederick M. Lowery becomes CEO18
  8. Feb 24, 20268-K Results of operations80
  9. Jan 12, 20268-K Executive or director change; Bylaws or fiscal year changed81
  10. Dec 23, 20258-K Entered a material agreement; New debt or obligation82
  11. Dec 23, 20258-K Executive or director change83
  12. Dec 9, 20258-K Entered a material agreement84
  13. Nov 4, 20258-K Results of operations85
  14. Feb 21, 2025New chief executive Thomas C. Popeck becomes CEO19
  15. May 31, 2024New chief executive Andrea Albertini becomes CEO20
  16. Sep 24, 2021New chief executive David B. Brous Jr. becomes CEO22
  17. Sep 24, 2021New chief executive Bradford C. Connett becomes CEO21
  18. May 20, 2016New chief executive Karen Prange becomes CEO23
  19. Dec 18, 2013New chief executive James P. Breslawski becomes CEO24
  20. Sep 27, 2012New chief executive Lonnie Shoff becomes CEO25
  21. Mar 3, 2006New chief executive Stanley M. Bergman becomes CEO26
  22. Nov 3, 1995Went public Listed on NASDAQ1
  23. 1932Founded Founded in Queens1

Calendar

Coming up

  1. Nov 3, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $1.38 a share, on Nov 4, 2025.86

When it reported results

  1. Aug 4, 2026Reported quarterly or annual results76
  2. May 5, 2026Reported quarterly or annual results79
  3. Feb 24, 2026Reported quarterly or annual results80
  4. Nov 4, 2025Reported quarterly or annual results85
  5. Aug 5, 2025Reported quarterly or annual results87
  6. May 5, 2025Reported quarterly or annual results88
  7. Feb 25, 2025Reported quarterly or annual results89
  8. Jan 29, 2025Reported quarterly or annual results90

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

487 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 54 major events, 298 insider forms, 33 large holders, 82 other. The latest 20:

  1. Oct 8, 20268-K EDGAR
  2. Sep 22, 20268-K EDGAR
  3. Sep 9, 20264 EDGAR
  4. Aug 14, 2026144 EDGAR
  5. Aug 6, 2026SCHEDULE 13G EDGAR
  6. Aug 4, 202610-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) EDGAR
  7. Aug 4, 20268-K CURRENT REPORT FILING EDGAR
  8. Jul 30, 20268-K EDGAR
  9. Jun 30, 2026144 EDGAR
  10. Jun 18, 202611-K ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS EDGAR
  11. Jun 16, 2026144 EDGAR
  12. Jun 15, 20264 EDGAR
  13. May 29, 2026SD SPECIALIZED DISCLOSURE REPORT FILED PURSUANT TO SECTION 1502 OF THE DODD-FRANK W EDGAR
  14. May 28, 20263 EDGAR
  15. May 26, 20264/A EDGAR
  16. May 22, 20264 EDGAR
  17. May 22, 20268-K EDGAR
  18. May 21, 20264 EDGAR
  19. May 12, 20264 EDGAR
  20. May 12, 2026DEFA14A EDGAR

The 487 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

48 open-market trades by officers, directors and large owners since October 2021: 3 buys and 45 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 11, 2026DANIEL WILLIAM KDirectorBuy10,000$69.19$691.9KForm 4
Mar 19, 2026Popeck Thomas CCEO, Henry Schein ProductsSale1,355$72.79$98.6KForm 4
Mar 10, 2026KUEHN KURT PDirectorSale2,844$78.96$224.6KForm 4
Mar 5, 2026LASKAWY PHILIP ADirectorSale2,844$80.36$228.5KForm 4
Mar 4, 2026MLOTEK MARK EEVP, Chief Strategic OfficerSale5,925$80.80$478.8KForm 4
Mar 2, 2026BERGMAN STANLEY MSale43,812$81.31$3.6MForm 4
Feb 27, 2026BERGMAN STANLEY MSale10,785$81.20$875.7KForm 4
Feb 26, 2026BERGMAN STANLEY MSale38,346$81.01$3.1MForm 4
Aug 7, 2025DANIEL WILLIAM KDirectorBuy10,000$67.08$670.8KForm 4
Mar 19, 2025LASKAWY PHILIP ADirectorSale2,604$71.04$185.0KForm 4
Mar 19, 2025Connett Bradford CCEO, NA Distribution GroupSale4,036$71.15$287.2KForm 4
Mar 5, 2025KUEHN KURT PDirectorSale2,787$71.55$199.4KForm 4
Nov 18, 2024Ettinger Michael SEVP & Chief Operating OfficerSale12,240$75.00$918.0KForm 4
Sep 6, 2024McGlynn LoreleiSVP, Chief Human Res. OfficerSale21,035$69.30$1.5MForm 4
Aug 14, 2024MLOTEK MARK EEVP, Chief Strategic OfficerSale3,000$69.12$207.4KForm 4
Jun 6, 2024Siegel WalterSr. VP & Chief Legal OfficerSale4,134$69.47$287.2KForm 4
Mar 20, 2024Connett Bradford CCEO, NA Distribution GroupSale6,430$74.28$477.6KForm 4
Mar 18, 2024BRESLAWSKI JAMES PPresidentSale2,907$74.37$216.2KForm 4
Mar 5, 2024LASKAWY PHILIP ADirectorSale4,278$76.29$326.4KForm 4
Mar 4, 2024BRESLAWSKI JAMES PPresidentSale2,907$76.50$222.4KForm 4

All 48 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Andrea AlbertiniChief Executive Officer, Global Distribution and Technology56$712.5K$3.4M101

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$533.1M 2008–2026
Money received by yearMoney received by year, 2008–2026: $533.1M in all. Federal loans $350.0K; Other federal assistance $33.8M; Federal contracts $499.0M.$0$25M$50M$75M$100M2008 · Other federal assistance: $2.5M2008 · Federal contracts: $35.4M20082009 · Federal loans: $350.0K2009 · Other federal assistance: $5.5M2009 · Federal contracts: $17.3M2010 · Other federal assistance: $5.5M2010 · Federal contracts: $19.6M20102011 · Other federal assistance: $6.5M2011 · Federal contracts: $19.2M2012 · Other federal assistance: $6.8M2012 · Federal contracts: $18.2M20122013 · Other federal assistance: $7.0M2013 · Federal contracts: $17.4M2014 · Federal contracts: $24.6M20142015 · Federal contracts: $37.8M2016 · Federal contracts: $34.5M20162017 · Federal contracts: $31.6M2018 · Federal contracts: $35.7M20182019 · Federal contracts: $25.8M2020 · Federal contracts: $23.8M20202021 · Federal contracts: $93.1M2022 · Federal contracts: $18.2M20222023 · Federal contracts: $17.4M2024 · Federal contracts: $16.4M20242026 · Federal contracts: $12.9M2026
Without federal contracts$34.1M 2008–2013
Without federal contractsWithout federal contracts, 2008–2013: $34.1M in all. Federal loans $350.0K; Other federal assistance $33.8M.$0$2M$4M$6M$8M2008 · Other federal assistance: $2.5M20082009 · Federal loans: $350.0K2009 · Other federal assistance: $5.5M2010 · Other federal assistance: $5.5M20102011 · Other federal assistance: $6.5M2012 · Other federal assistance: $6.8M20122013 · Other federal assistance: $7.0M2013
Figures by year
YearFederal loansOther federal assistanceFederal contractsTotal
2026––$12.9M$12.9M
2024––$16.4M$16.4M
2023––$17.4M$17.4M
2022––$18.2M$18.2M
2021––$93.1M$93.1M
2020––$23.8M$23.8M
2019––$25.8M$25.8M
2018––$35.7M$35.7M
2017––$31.6M$31.6M
2016––$34.5M$34.5M
2015––$37.8M$37.8M
2014––$24.6M$24.6M
2013–$7.0M$17.4M$24.4M
2012–$6.8M$18.2M$25.0M
2011–$6.5M$19.2M$25.7M
2010–$5.5M$19.6M$25.1M
2009$350.0K$5.5M$17.3M$23.2M
2008–$2.5M$35.4M$37.9M

Federal awards

Obligated amounts from USAspending.gov102, by calendar year, 2008–2026, for 12 registered units, including subsidiaries under the same parent. Obligations are what agencies committed, not always what was paid out. Contracts pay for goods and services; grants, loans and direct payments are assistance. Loans are charted at the face value of the loans listed here. An award’s amount below is its lifetime total, and some began before the years charted.

Largest federal loans

  1. Nov 23, 2009$350.0K from Small Business Administration: 7(A) Loan Guarantees103 To MCALLISTER SOFTWARE SYSTEMS, LLC Award 3702345008

Largest contracts

  1. Apr 18, 2021$28.6M from Office of Assistant Secretary for Preparedness and Response: Includes all services as necessary for the continuous vmi of up to 80,000 pallets of gfp, subject to and in accordance with sow in section c104 To HENRY SCHEIN, INC. Award 75A50121C00041
  2. Dec 6, 2011$4.1M from Indian Health Service: Medical and surgical instruments, equipment, and supplies105 To HENRY SCHEIN, INC. Award HHSI247201200023G
  3. Jun 29, 2006$2.6M from Centers for Disease Control and Prevention: 000hcj44-2006-28094 - 2006 adult vaccine contracts106 To HENRY SCHEIN, INC. Award HHSD200200616191C
  4. Sep 25, 2014$1.8M from Department of Veterans Affairs: Dental supplies and equipment to furnish the new decatur specialty care clinic107 To HENRY SCHEIN, INC. Award VA24714F3634
  5. Oct 1, 2015$1.6M from Department of the Navy: Reagents, laboratory, usnh yokosuka108 To HENRY SCHEIN, INC. Award N0040616P0015

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Kohlberg Kravis Roberts & Co. L.P.15,652,032$1.3B23.9%No change
Fmr LLC7,553,901$630.9M0.0%+1,831,752
BlackRock, Inc.7,024,663$586.7M0.0%+1,674
Artisan Partners Limited Partnership6,467,467$540.2M0.9%−105,556
Vanguard Capital Management LLC6,346,669$530.1M0.0%−76,498
Jpmorgan Chase & Co4,342,929$366.4M0.0%−219,583
State Street Corp4,305,276$359.6M0.0%−73,705
Vanguard Portfolio Management LLC4,133,442$345.2M0.0%−61,478
American Century Companies Inc3,457,175$288.7M0.1%−137,184
Dimensional Fund Advisors LP3,394,242$283.5M0.1%+521,238
Southpoint Capital Advisors LP3,300,000$275.6M6.3%+100,000
Invesco Ltd.3,150,237$263.1M0.0%−1,736,246
Citadel Advisors LLC2,921,103$244.0M0.1%+2,887,920
Geode Capital Management, LLC2,729,030$227.5M0.0%−41,220
Palestra Capital Management LLC2,446,691$204.3M6.9%−965,976
Bank Of Montreal /can/2,115,510$176.7M0.1%+71,540
Morgan Stanley2,100,819$175.5M0.0%+674,121
Fiduciary Management Inc /wi/1,817,353$151.8M2.2%−136,730
Lyrical Asset Management LP1,467,351$122.6M1.6%−77,091
UBS Group AG1,336,843$111.7M0.0%+281,377
Swedbank AB1,310,822$109.5M0.1%No change
M.D. Sass, LLC1,286,942$107.5M7.1%+13,626
Snyder Capital Management L P1,285,225$107.3M1.9%+16,416
Schroder Investment Management Group1,272,537$107.3M0.1%−241,848
Norges Bank1,237,832$103.4M0.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

10 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Apr 8, 2025Robert P. Bresnahan, Jr.Republican, HouseBuy$1,001 - $15,000−16.7%Report
Apr 1, 2025Julie JohnsonDemocratic, HouseSale$1,001 - $15,000+11.6%Report
Mar 31, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseSale$1,001 - $15,000+11.0%Report
Jan 6, 2022Susan M. CollinsRepublican, SenateSale$15,001 - $50,000+53.2%Report
Aug 7, 2020Lois FrankelDemocratic, HouseSale$1,001 - $15,000+102.4%Report
Apr 17, 2018Thomas R. SuozziDemocratic, HouseSale$15,001 - $50,000+129.5%Report
Mar 29, 2018Thomas R. SuozziDemocratic, HousePartial sale$1,001 - $15,000+128.3%Report
Dec 6, 2017Thomas R. SuozziDemocratic, HouseSale$15,001 - $50,000+129.1%Report
Dec 6, 2017Thomas R. SuozziDemocratic, HousePartial sale$15,001 - $50,000+129.1%Report
Aug 17, 2017Thomas R. SuozziDemocratic, HouseBuy$15,001 - $50,000−186.7%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Henry Schein is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHENRY SCHEIN INC2
  • CIK0001000228
  • Employer ID (EIN)11-3136595109
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company109
  • Incorporated inDelaware109
  • Fiscal year endsDecember 262
  • Industry code (SIC)5047 Wholesale-Medical, Dental & Hospital Equipment & Supplies2
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance2
  • Business address135 Duryea Rd, Melville, NY 117472
  • Phone63184355002
  • Shares outstanding111,446,542 as of Jul 27, 202616
  • Public float$8.9B as of Jun 28, 2025109
  • AuditorBDO USA, P.C., New York, New York PCAOB ID 243; it also attests to the company’s internal control over financial reporting109
  • On EDGAR sinceMay 13, 19962
  • Filings2,152 in all: 4 (1,265), 8-K (235), SC 13G/A (118), 10-Q (92), 3 (46), 5 (39), 144 (33), DEFA14A (31)2
    All 48 form types

    DEF 14A (30), 10-K (29), CORRESP (25), UPLOAD (25), 425 (22), SC 13G (22), 11-K (16), S-8 (13), SD (13), 4/A (11), 424B3 (9), S-3 (9), SCHEDULE 13D/A (7), ARS (6), POS AM (6), PRE 14A (5), S-3/A (5), SCHEDULE 13G/A (5), 8-K/A (4), CT ORDER (4), SCHEDULE 13G (3), 10-K405/A (2), 5/A (2), S-4 (2), SC 13D (2), SC 13D/A (2), 10-K/A (1), 10-Q/A (1), 10KSB40 (1), 3/A (1), 424B4 (1), 8-A12G (1), DEFM14A (1), DEFR14A (1), NO ACT (1), NT 10-Q (1), RW (1), S-1 (1), S-1/A (1), SCHEDULE 13D (1)

  • Latest filingsAnnual report (10-K) Feb 24, 2026
    Quarterly report (10-Q) Aug 4, 2026
    Proxy statement (DEF 14A) Apr 8, 2026
    Latest 8-K (8-K) Oct 8, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $.01 per shareHSICNASDAQ

From the cover page of the 10-K filed Feb 24, 2026 (Section 12(b) of the Exchange Act).109

Risk factors and legal proceedings

The risks Henry Schein names in Item 1A of its 10-K filed Feb 24, 2026: 19 risks under these headings, as written.109

  • Proprietary Rights
  • Employees and Human Capital
  • respects and supports one another.
  • Available Information
  • Information about our Executive Officers
  • Andrea Albertini
  • Michael S. Ettinger
  • Mark E. Mlotek
  • Christine Sheehy
  • Other Executive Management
  • R. Steven Boggan
  • David Kochman
The other 18 risks
  • James Mullins
  • Kelly Murphy
  • Christopher Pendergast
  • COMPANY RISKS
  • We are dependent upon third parties for the manufacture/supply of a significant volume of our products and
  • We may be unsuccessful in achieving our strategic growth objectives.
  • Our business could be affected by the Strategic Partnership Agreement with KKR.
  • Our future growth (especially for our Global Technology and Global Specialty Products segments) is dependent
  • technologies that achieve market acceptance with acceptable margins.
  • over the market price of their shares.
  • that such sales could materially adversely affect our relationships with suppliers.
  • Our business could be affected by activist investors.
  • INDUSTRY RISKS
  • extended period of time.
  • materially adversely affect our business.
  • competitive disadvantage.
  • MACRO-ECONOMIC AND POLITICAL RISKS
  • results of operations and financial condition.
  • The EU Medical Device Regulation (“MDR”) may adversely affect our business.
  • on the protection of persons who report breaches of
  • We face inherent risk of exposure to product liability, intellectual property infringement and other claims in the
  • event that the use of the products we sell results in injury.
  • Customs policies or legislative import restrictions could hinder the Company’s ability to import goods necessary
  • products that we distribute.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceHSIC quote
  6. 6
    Company websiteHenry Schein logo
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109